Patient verdicts

Because that's the real count. We're opening verdicts with zero entries on purpose. Seeded reviews are a trust killer, and this category is full of them. Every verdict you read here will come from a real patient who answered the same 12 questions as everyone else.

They cover week 1, what surprised you, what you'd tell past-you, the hardest moment, first visible change, body-shape week, food-noise timeline, social impact, a ranking of your side effects, whether the cost was worth it, whether you'd do it again, and advice for someone in your demographic. Same 12 for everyone so you can compare like-for-like.

Two things. First, every verdict answers the same structured questions so you can actually filter and compare. Second, no free-text star ratings, because star ratings incentivize extremes. A verdict is a structured account of a specific treatment window for a specific person.

The STEP 1 trial (Wilding et al., NEJM, 2021) found an average 14.9 percent body-weight reduction at 68 weeks for semaglutide 2.4 mg. The SURMOUNT-1 trial (Jastreboff et al., NEJM, 2022) found 20.9 percent at 72 weeks for tirzepatide 15 mg. Individual verdicts here will vary widely around those averages.

Yes. Medication, age bracket, starting BMI band, and sex at birth. Once enough verdicts stack up in a filter, you get a snapshot of how the treatment looks for people similar to you. Early on, filters will return empty results. That's the real data, not an error.

Every submission goes through moderation before it publishes. We check for patterns like copied marketing copy, competitor attacks, or inconsistent answers. We'd rather publish slowly than publish garbage.